Allient Inc Dossier - Source-backed chat

Allient Inc

ALNTNASDAQ

SectorInformation Technology

IndustryElectronic Components

Beta (adjusted)1.41

Intrinsic Value $51.17median of 6 methods · middle span $41-$60based on filings through 30 Jun 2026

Market Price $111.60Price as of 30 Sep 2026

Significantly overvaluedIntrinsic value is 54% below the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

marker beyond scale (-54%)

Data confidence Sign in to view data confidence

Market Cap $1.9B

Enterprise Value $2B

Shares Outstanding 17M diluted

Moat Rating None

Next Earnings Date4 Nov 2026

Last ex-dividend19 Aug 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Allient Inc. (formerly Allied Motion Technologies) is executing a successful operational turnaround driven by its 'Simplify to Accelerate NOW' (STAN) program, which is structurally expanding gross margins. Despite near-term headwinds from facility transition costs and modest organic constant-currency growth, the company's record book-to-bill ratio of 1.14x and robust backlog of $251 million provide strong short-term revenue visibility. Long-term secular tailwinds in aerospace & defense, medical robotics, and data center infrastructure position Allient to capture high-margin, specialized system-level opportunities.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets5 analysts · as of 18 Aug 2026

Low · most bearish analyst$90.00

Mean target$118.00

High · most bullish analyst$130.00

Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

The bear case reflects prolonged transition headwinds at the Dothan facility, persistent tariff pressures, and a slower recovery in the medical mobility and general industrial automation markets, limiting margin expansion and keeping organic growth flat.

Base CaseCentral scenario

The base case assumes successful completion of the Dothan facility transition by the end of Q3 2026, allowing the full benefits of the STAN program to materialize in the second half of the year. Revenue growth is supported by strong order momentum in industrial automation and defense, while gross margins stabilize above 32.5%.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strong order momentum with a multiyear high book-to-bill ratio of 1.14x in Q1 2026.
Structural gross margin expansion (up 50 bps YoY to 32.7% in Q1 2026) driven by the STAN program.
Robust backlog of $251 million providing clear short-term revenue visibility.
Strategic alignment with high-growth secular markets including aerospace & defense, medical robotics, and data centers.

Key Investment Risks

Near-term margin pressure from elevated Dothan facility transition and restructuring costs.
Potential tariff and trade policy headwinds impacting global supply chain costs.
Modest organic revenue growth (1% on a constant-currency basis in Q1 2026) indicating soft underlying demand in certain markets.

Thesis Invalidation Triggers

Failure to eliminate Dothan transition costs by the end of Q3 2026.
A sustained drop in the book-to-bill ratio below 1.00x for consecutive quarters.
Significant deterioration in gross margins below 31% due to unmitigated tariff pressures.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.